NCT00290966
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
Not specified
Clinical trial condition
Gastrointestinal Neoplasms
Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.
9,338 public trials
2,094 recruiting studies
Gastrointestinal Neoplasms trial results
NCT00096707
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +24 more
- Locations
-
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Institute for Drug Development Cancer Therapy & Research Center San Antonio, Texas, United States
NCT00215462
- Conditions
- Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00123851
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +13 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00165464
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +11 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Faulkner Hospital Boston, Massachusetts, United States
NCT00165191
- Conditions
- Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenocarcinoma of GE Junction, +12 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure
NCT00242788
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Research Site Girona, Spain
- Research Site Leganés, Spain
- Research Site Madrid, Spain
- Research Site Málaga, Spain
NCT00275210
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +8 more
- Locations
-
- sanofi-aventis Australia & New Zealand administrative office Macquarie Park, New South Wales, Australia
- Sanofi-Aventis Administrative Office Vienna, Austria
- Sanofi-Aventis Administrative Office Diegem, Belgium
- Sanofi-Aventis Administrative Office Hørsholm, Denmark
NCT00485316
- Conditions
- Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +10 more
- Locations
-
- Prince of Wales Hospital Hong Kong SAR, China
NCT00379132
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +41 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Northwestern University, The Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- University of Chicago Chicago, Illinois, United States
- Tufts - New England Medical Center Boston, Massachusetts, United States